CPRC
ELV icon

Consolidated Portfolio Review Corp’s Elevance Health ELV Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-553
Closed -$215K – 464
2025
Q2 		$215K Hold
553
– – 0.03% 418
2025
Q1 		$241K Sell
553
-40
-7% -$16.1K 0.04% 332
2024
Q4 		$219K Buy
+593
New +$248K 0.03% 343

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Consolidated Portfolio Review Corp's ELV Position: Q3 2025 in Review

Consolidated Portfolio Review Corp sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 553 shares — an estimated $215K sold.

Consolidated Portfolio Review Corp first reported a position in ELV in Q4 2024 and held it in 3 quarters. The position peaked at $241K in Q1 2025. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Consolidated Portfolio Review Corp reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 553 Elevance Health shares in Q3 2025, an estimated $215K.
  • Consolidated Portfolio Review Corp first reported a position in Elevance Health in Q4 2024 and held it in 3 quarters.
  • Consolidated Portfolio Review Corp's Elevance Health position peaked at $241K in Q1 2025.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q3 2025, filed 12 Nov 2025.